Haleon Corp - HLN Net Assets per Single Share

Public company logo of haleon.com (HLN)

The book value per share demonstrates the dominance of Haleon plc (HLN) in the over-the-counter segment, where brand loyalty protects against dumping, and the value of 4.98 reflects this status. Revenues are based on global demand from millions of people for hygiene and health products. Sales stability regardless of crises confirms the defensive qualities of the asset.

Accounting Value of a Share: Haleon PLC (HLN) for 04/28/2023 - 10/28/2026
Signature product of Haleon

Haleon plc relies on steady demand for the Sensodyne and Voltaren brands, creating a protected market niche. The capitalization of these intangible assets and resources forms the net asset value divided by the number of shares. This metric determines the estimated value of a shareholder's equity stake in the company. The trend in equity per share demonstrates the pace at which the financial foundation is strengthening. The growing trend confirms an expanding asset base, minimizing the risks of business impairment.

Competitor analysis

Kenvue Corp (KVUE) - Net Assets per Single Share|VRNA: Equity per Share|Net Assets per Single Share Jyong Biotech Ltd (MENS)|ligand.com (LGND) - Share Book Value|AMRX - Book Value per Share|Accounting Value of a Share Perrigo Company PLC|Book Value per Share ALVO|Book Value per Share LQDA (Liquidia Inc.)|Net Assets per Single Share Galapagos NV|anipharmaceuticals.com - Accounting Value of a Share|MNKD: Net Assets per Single Share|AMPH - Accounting Value per Share|PCRX: Book Value per Share|Book Value per Share ARS Corp|TBPH - Accounting Value per Share|Accounting Value of a Share AQST|scPharmaceuticals Inc. - Net Assets per Single Share|Net Asset Value per Share tectonictx.com TECX|Accounting Value per Share Tonix Pharmaceuticals Inc. (TNXP)|Book Price of a Share SXT Pharmaceuticals SXTC|Book Value per Share Eupraxia Pharma (EPRX)|BHST - Accounting Value of a Share|Book Value per Share EXOZ|ORMP (Oramed Pharmaceuticals Inc.) - Net Asset Value per Share|ENTX - Net Assets per Single Share|Accounting Value of a Share MindWalk Therapeutics|ABVC BioPharma (ABVC) - Book Value per Share|Accounting Value of a Share cumberlandpharma.com (CPIX)|Book Value per Share QNTM (Quantum BioPharma)|FibroGen Inc - Book Value per Share|TELO - Net Assets per Single Share|RANI - Net Assets per Single Share|Book Value per Share SNYR|RLYB (Rallybio) - Net Asset Value per Share|Net Assets per Single Share LEXX (Lexaria Bioscience Corp)|Net Asset Value per Share PULM|Net Assets per Single Share Pheton Holdings Ltd PTHL|Equity per Share aptorumgroup.com APM|Accounting Value per Share Lyra Therapeutics, Inc.|Impact BioMedical, Inc. - Accounting Value of a Share|Net Assets per Single Share TNF Pharma|YCBD: Share Book Value|PainReform Limited (PRFX) - Net Assets per Single Share|Altamira Therapeutics Ltd. (CYTO) - Net Assets per Single Share|Book Value per Share LIPO|Accounting Value per Share optinose.com|Pieris Pharmaceuticals, Inc. (PIRS) - Book Value per Share|Accounting Value of a Share PROC (Procaps Group)|Net Assets per Single Share Petros PTPI|Qilian International Corp - Net Assets per Single Share|Acelyrin, Inc. (SLRN) - Net Assets per Single Share|TFFP: Equity per Share